SKAN Group AG - Asset Resilience Ratio

Latest as of December 2025: 19.56%

SKAN Group AG (SKAN) has an Asset Resilience Ratio of 19.56% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check SKAN Group AG PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets

CHF94.08 Million
≈ $118.94 Million USD Cash + Short-term Investments

Total Assets

CHF481.08 Million
≈ $608.21 Million USD All company assets

Resilience Assessment

Good
Financial Resilience Level

Asset Resilience Ratio Trend (2016–2025)

This chart shows how SKAN Group AG's Asset Resilience Ratio has changed over time. See SKAN equity financing ratio to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down SKAN Group AG's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is SKAN Group AG worth.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CHF94.08 Million 19.56%
Short-term Investments CHF0.00 0%
Total Liquid Assets CHF94.08 Million 19.56%

Asset Resilience Insights

  • Good Liquidity Position: SKAN Group AG maintains a healthy 19.56% of assets in liquid form.
  • This level provides good financial flexibility while maintaining productive asset deployment.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

SKAN Group AG Industry Peers by Asset Resilience Ratio

Compare SKAN Group AG's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
QITIAN Technology Group Co Ltd
SHE:300061
Medical Instruments & Supplies 0.00%
Visco Vision Inc.
TW:6782
Medical Instruments & Supplies 0.98%
Daxor Corporation
NASDAQ:DXR
Medical Instruments & Supplies 65.10%
GETS Global Bhd
KLSE:5079
Medical Instruments & Supplies 0.03%
Osteopore Ltd
AU:OSX
Medical Instruments & Supplies 22.60%
Safe Orthopaedics SA
PA:ALSAF
Medical Instruments & Supplies 2.20%
Ansell Ltd
AU:ANN
Medical Instruments & Supplies 7.53%
Nanosonics Ltd
AU:NAN
Medical Instruments & Supplies 46.84%

Annual Asset Resilience Ratio for SKAN Group AG (2016–2025)

The table below shows the annual Asset Resilience Ratio data for SKAN Group AG.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 19.56% CHF94.08 Million
≈ $118.94 Million
CHF481.08 Million
≈ $608.21 Million
+3.51pp
2024-12-31 16.05% CHF61.71 Million
≈ $78.02 Million
CHF384.49 Million
≈ $486.09 Million
-6.72pp
2023-12-31 22.77% CHF85.03 Million
≈ $107.50 Million
CHF373.45 Million
≈ $472.14 Million
-12.25pp
2022-12-31 35.02% CHF135.98 Million
≈ $171.92 Million
CHF388.35 Million
≈ $490.98 Million
-4.58pp
2021-12-31 39.60% CHF131.43 Million
≈ $166.16 Million
CHF331.92 Million
≈ $419.64 Million
+15.06pp
2020-12-31 24.54% CHF63.68 Million
≈ $80.51 Million
CHF259.54 Million
≈ $328.12 Million
+22.92pp
2019-12-31 1.62% CHF1.82 Million
≈ $2.30 Million
CHF112.57 Million
≈ $142.32 Million
+1.20pp
2018-12-31 0.42% CHF406.90K
≈ $514.43K
CHF96.50 Million
≈ $122.00 Million
-11.66pp
2017-12-31 12.08% CHF10.55 Million
≈ $13.34 Million
CHF87.35 Million
≈ $110.44 Million
-3.00pp
2016-12-31 15.08% CHF10.87 Million
≈ $13.74 Million
CHF72.08 Million
≈ $91.13 Million
--
pp = percentage points

About SKAN Group AG

SW:SKAN Switzerland Medical Instruments & Supplies
Market Cap
$1.39 Billion
CHF1.10 Billion CHF
Market Cap Rank
#8799 Global
#115 in Switzerland
Share Price
CHF48.75
Change (1 day)
-2.50%
52-Week Range
CHF40.40 - CHF76.40
All Time High
CHF90.75
About

SKAN Group AG, together with its subsidiaries, provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally. It operates in two segments, Equipment and Solutions; and Services and Consumables. The company offers accessories, biological indicators, digital ventures, isolators, cleanroom, laminar f… Read more